消炎痛栓对ERCP治疗急性胆源性胰腺炎疗效的影响  

Effect of Indomethacin Suppository on the Efficacy of ERCP in the Treatment of Acute Biliary Pancreatitis

作　　者：何艳杰 HE Yanjie(Chaoyang Central Hospital,Chaoyang 122000,China)

机构地区：[1]辽宁省朝阳市中心医院,辽宁朝阳122000

出　　处：《中国医药指南》2020年第33期118-119,共2页Guide of China Medicine

摘　　要：目的研究消炎痛栓对ERCP治疗急性胆源性胰腺炎疗效的影响。方法从我院临床资料中选定56例急性胆源性胰腺炎实施ERCP治疗患者,时间2018年3月至2019年2月,利用信封随机分组方案分为试验组(28例,使用消炎痛栓)及对照组(28例,未使用消炎痛栓)。结果试验组术后第3日白细胞、血淀粉酶、总胆红素、丙氨酸氨基转移酶、血清C反应蛋白、胃肠道恢复时间、住院时间、腹痛缓解时间、并发症发生率、住院总费用均少于对照组,组间对比差异明显(P<0.05);对比分析两组患者术前各项临床指标,差异不明显(P>0.05)。结论利用消炎痛栓可以预防ERCP治疗急性胆源性胰腺炎发生,效果满意。Objective Effect of indomethacin suppository on ERCP in the treatment of acute biliary pancreatitis.Methods From the clinical data of our hospital,56 patients with acute biliary pancreatitis were treated with ERCP.From March 2018 to February 2019,the randomized grouping method was used to divide into experimental group(28 cases,use indomethacin suppository)and the control group(28 cases,no indomethacin suppository).Results The white blood cells,blood amylase,total bilirubin,alanine aminotransferase,serum C-reactive protein,gastrointestinal recovery time,hospitalization time,abdominal pain relief time,incidence of complications and total hospitalization expenses in the experimental group were less than those in the control group on the third day after operation(P<0.05);there was no significant difference in the preoperative clinical indexes between the two groups(P>0.05).Conclusions Indomethacin suppository can prevent the occurrence of ERCP in the treatment of acute biliary pancreatitis with satisfactory results.

关 键 词：急性胆源性胰腺炎 消炎痛栓 ERCP治疗 疗效 

分 类 号：R576[医药卫生—消化系统]